Chang-gui Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Journal: The Lancet. Infectious diseases
Published: December 03, 2023
Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females.
Journal: Human vaccines & immunotherapeutics
Published: May 30, 2023
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: December 04, 2022
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models.
Journal: Emerging microbes & infections
Published: November 26, 2020
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.
Journal: Human vaccines & immunotherapeutics
Published: June 17, 2020
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial.
Journal: Human vaccines & immunotherapeutics
Published: November 27, 2019
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women.
Journal: Science China. Life sciences
Published: March 12, 2019
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Journal: Journal of the National Cancer Institute
Published: January 15, 2019
Sequence Analysis and Comparison of the Key Genes of Domestic Live Attenuated Varicella Vaccine.
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Published: November 11, 2017
Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial.
Journal: Vaccine
Published: May 03, 2015
Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: October 20, 2014
Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.
Journal: Human vaccines & immunotherapeutics
Published: January 04, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026